Antimicrobial Pharmacodynamics and Therapeutics Group (APT)

The Antimicrobial Pharmacodynamics and Therapeutics (APT) Group provides preclinical and early phase clinical support to ensure new drugs are developed in a streamlined manner.

Led by Professor Shampa Das, the APT Accelerator supports industry to develop new antibiotics and other antimicrobial agents to address unmet medical needs related to antimicrobial resistance. 

Led by Professor William Hope OBE, the Antimicrobials for Global Health group focuses on the development of new therapeutic approaches to urgent threats posed by AMR using state-of-the-art pharmacodynamic and pharmacometric tools.

Back to: Institute of Systems, Molecular and Integrative Biology